SE0102204D0 - New method - Google Patents

New method

Info

Publication number
SE0102204D0
SE0102204D0 SE0102204A SE0102204A SE0102204D0 SE 0102204 D0 SE0102204 D0 SE 0102204D0 SE 0102204 A SE0102204 A SE 0102204A SE 0102204 A SE0102204 A SE 0102204A SE 0102204 D0 SE0102204 D0 SE 0102204D0
Authority
SE
Sweden
Prior art keywords
gene
vector
essential
cell
antibiotic resistance
Prior art date
Application number
SE0102204A
Other languages
English (en)
Swedish (sv)
Inventor
Leif Isaksson
Peter Joergen Haegg
Farhad Maruf Abdulkarim
Original Assignee
Leif Isaksson
Peter Joergen Haegg
Farhad Maruf Abdulkarim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leif Isaksson, Peter Joergen Haegg, Farhad Maruf Abdulkarim filed Critical Leif Isaksson
Priority to SE0102204A priority Critical patent/SE0102204D0/xx
Publication of SE0102204D0 publication Critical patent/SE0102204D0/xx
Priority to DK02740737T priority patent/DK1404847T3/da
Priority to CN02812556.8A priority patent/CN1249244C/zh
Priority to EP02740737A priority patent/EP1404847B1/en
Priority to AU2002314183A priority patent/AU2002314183A1/en
Priority to DE60204317T priority patent/DE60204317T2/de
Priority to US10/481,038 priority patent/US20040234984A1/en
Priority to PCT/EP2002/006780 priority patent/WO2003000881A2/en
Priority to AT02740737T priority patent/ATE296354T1/de
Priority to ES02740737T priority patent/ES2240758T3/es
Priority to ZA2003/09767A priority patent/ZA200309767B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
SE0102204A 2001-06-21 2001-06-21 New method SE0102204D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0102204A SE0102204D0 (sv) 2001-06-21 2001-06-21 New method
ES02740737T ES2240758T3 (es) 2001-06-21 2002-06-19 Metodo de estibilizacion de plasmidos mediante delecion in vivo de la resistencia a antibioticos y seleccion con un gen esencial.
AU2002314183A AU2002314183A1 (en) 2001-06-21 2002-06-19 Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene
CN02812556.8A CN1249244C (zh) 2001-06-21 2002-06-19 去除抗生素耐药性和/或使质粒稳定的方法,该方法构建的载体和转化的宿主细胞及其应用
EP02740737A EP1404847B1 (en) 2001-06-21 2002-06-19 Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene
DK02740737T DK1404847T3 (da) 2001-06-21 2002-06-19 Fremgangsmåde til plasmidstabilisering ved in vivo at fjerne antibiotikaresistensen og selektere med et essentielt gen
DE60204317T DE60204317T2 (de) 2001-06-21 2002-06-19 Methode zur plasmidstabilisierung durch in vivo deletion der antibiotikaresistenz und selektion mit einem essentiellen gen
US10/481,038 US20040234984A1 (en) 2001-06-21 2002-06-19 Method
PCT/EP2002/006780 WO2003000881A2 (en) 2001-06-21 2002-06-19 Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene
AT02740737T ATE296354T1 (de) 2001-06-21 2002-06-19 Methode zur plasmidstabilisierung durch in vivo deletion der antibiotikaresistenz und selektion mit einem essentiellen gen
ZA2003/09767A ZA200309767B (en) 2001-06-21 2003-12-17 Method of plasmid stabilisation by in vivo deleting the antibiotic resistance and selecting with an essential gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102204A SE0102204D0 (sv) 2001-06-21 2001-06-21 New method

Publications (1)

Publication Number Publication Date
SE0102204D0 true SE0102204D0 (sv) 2001-06-21

Family

ID=20284558

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102204A SE0102204D0 (sv) 2001-06-21 2001-06-21 New method

Country Status (10)

Country Link
US (1) US20040234984A1 (zh)
EP (1) EP1404847B1 (zh)
CN (1) CN1249244C (zh)
AT (1) ATE296354T1 (zh)
AU (1) AU2002314183A1 (zh)
DE (1) DE60204317T2 (zh)
ES (1) ES2240758T3 (zh)
SE (1) SE0102204D0 (zh)
WO (1) WO2003000881A2 (zh)
ZA (1) ZA200309767B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868422B1 (fr) * 2004-03-31 2006-07-14 Aventis Pharma Sa Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
TWI311152B (en) * 2004-09-17 2009-06-21 Boehringer Ingelheim Rcv Gmbh & Co K Host-vector system for antibiotic-free cole1 plasmid propagation
DK2683732T3 (en) * 2011-03-11 2016-12-12 Dsm Ip Assets Bv Vector-host-system
US10987432B2 (en) * 2013-09-05 2021-04-27 The University Of Hong Kong Therapeutic delivery and expression system, methods and uses thereof
HUE045556T2 (hu) * 2013-12-20 2020-01-28 Basf Se Eljárás egy kívánt fehérje elõállítására mikrobiális gazdaszervezetben
WO2017101958A1 (en) * 2015-12-18 2017-06-22 Glycom A/S Fermentative production of oligosaccharides
RU2752608C2 (ru) 2016-11-01 2021-07-29 Ново Нордиск А/С Толерогенная днк-вакцина
RU2712838C1 (ru) * 2018-09-04 2020-01-31 Генетик Диагностик Энд Терапи 21 Лтд Генотерапевтический ДНК-вектор GDTT1.8NAS12, способ его получения, штамм Escherichia coli JM110-NAS, способ его получения, штамм Escherichia coli JM110-NAS/GDTT1.8NAS12, несущий генотерапевтический ДНК-вектор GDTT1.8NAS12, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine
WO2022243399A1 (en) 2021-05-20 2022-11-24 Gen-H Genetic Engineering Heidelberg Gmbh Microorganism strain and method for antibiotic-free plasmid-based fermentation
WO2023166132A1 (en) 2022-03-04 2023-09-07 Gen-H Genetic Engineering Heidelberg Gmbh Microorganism strain for antibiotic-free plasmid-based fermentation and method for generation thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0972838B1 (en) * 1998-07-15 2004-09-15 Roche Diagnostics GmbH Escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
US6291245B1 (en) * 1998-07-15 2001-09-18 Roche Diagnostics Gmbh Host-vector system
FR2784394B1 (fr) * 1998-10-09 2001-01-05 Lesaffre & Cie Cassette d'integration-excision

Also Published As

Publication number Publication date
EP1404847B1 (en) 2005-05-25
US20040234984A1 (en) 2004-11-25
ES2240758T3 (es) 2005-10-16
DE60204317D1 (de) 2005-06-30
CN1518599A (zh) 2004-08-04
ZA200309767B (en) 2005-07-27
CN1249244C (zh) 2006-04-05
WO2003000881A2 (en) 2003-01-03
ATE296354T1 (de) 2005-06-15
AU2002314183A1 (en) 2003-01-08
EP1404847A2 (en) 2004-04-07
DE60204317T2 (de) 2006-01-26
WO2003000881A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
Studier Bacteriophage T7: Genetic and biochemical analysis of this simple phage gives information about basic genetic processes.
EP0856059B1 (en) Methods for production of recombinant plasmids
DK1446489T3 (da) Intakte miniceller som vektorer for DNA-overførsel og genterapi in vitro og in vivo
DE3650788D1 (de) Produktion des pluripotenten Granulozyten-Koloniestimulierungsfaktors
SE0102204D0 (sv) New method
EP0088195A3 (en) Messenger rna, production and use thereof
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
Rak et al. Expression of two proteins from overlapping and oppositely oriented genes on transposable DNA insertion element IS 5
HUP9800329A2 (hu) Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására
JPH02247198A (ja) 大腸菌でペプチドを分泌させるためのシグナルペプチドおよびその取得方法
PL1675956T3 (pl) Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
Wang et al. pDUAL: a transposon-based cosmid cloning vector for generating nested deletions and DNA sequencing templates in vivo.
CN109575116A (zh) 一种线粒体定位导肽及其发现方法与应用
AR026571A1 (es) Genes del musgo de la physcomitrella patens que codifican proteinas que participan en la sintesis de los acidos grasos poliinsaturados y lipidos
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
NO20044947L (no) MUC-1 antigen med redusert antall VNTR gjentagene enheter
Hori et al. Artificial zinc finger peptide containing a novel His4 domain
FI902569A0 (fi) Producering av till gonorre anslutande pi-proteiner och vaccin.
Tanaka et al. Construction and characterization of a chimeric plasmid composed of DNA from Escherichia coli and Drosophila melanogaster
Perenkov et al. In vitro transcribed RNA-based platform vaccines: past, present, and future
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
EP4121531A1 (en) Compositions and methods comprising improved guide rnas
EP3885430A1 (en) Medium for inducing plasmid copy number increase and application thereof
CN102559725A (zh) 人干细胞生长因子及其聚乙二醇修饰化产物的生产方法及用途
DE602004029158D1 (en) Archäen-expressionssystem